Corentec Co., Ltd. (KOSDAQ:104540)
5,700.00
-170.00 (-2.90%)
At close: Apr 3, 2026
Corentec Revenue
In the year 2025, Corentec had annual revenue of 100.43B KRW with 17.33% growth. Corentec had revenue of 28.61B in the quarter ending December 31, 2025, with 9.01% growth.
Revenue
100.43B
Revenue Growth
+17.33%
P/S Ratio
0.73
Revenue / Employee
567.39M
Employees
177
Market Cap
72.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.43B | 14.83B | 17.33% |
| Dec 31, 2024 | 85.59B | -6.45B | -7.01% |
| Dec 31, 2023 | 92.05B | 28.14B | 44.03% |
| Dec 31, 2022 | 63.91B | 19.28B | 43.20% |
| Dec 31, 2021 | 44.63B | 4.13B | 10.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 114.25B |
| Synergy Innovation | 113.05B |
| M.I.TECH Co.,Ltd | 67.15B |
| BIOBIJOU | 28.49B |
| Alpha AI | 25.98B |
| Sanigen Co. | 15.35B |
| Finemedix | 9.52B |
| Genolution | 9.40B |